MedMira Case
MedMira Laboratories
1. What changes in the environment made it possible to consider the launch of an OTC Aids Test? Be specific.
The launch of an OTC Aids Test in United States was only possible to be considered after some changes in the environment.
Due to growing incidences of infectious diseases (HIV, Hepatitis
C,…) there was a need to do something in order to overcome this issue that affected so many people. So MedMira Laboratories decided to develop rapid tests able to give accurate diagnosis that allowed healthcare providers to deliver effective treatment faster.
In the past years most of the HIV tests were performed using conventional testing technology, which required a minimum of 2 to
8 hours to produce results, highly trained laboratory personnel and special equipment to perform and interpret the tests. In order to decrease costs, these testes were normally performed in batches, which delayed the process for patients to get their results up to two weeks. So rapid HIV tests emerged as a good, faster and cheaper alternative for conventional testing technology. Rapid HIV testing was a growing market worldwide.
Advancements made in anti-retroviral treatment were also an important step to the launch of an OTC Aids Test. It changed the way people faced a positive result. Until then a positive result was often seen as a death sentence. But with these advancements made in anti-retroviral treatment it had became a much more manageable illness. This help reduced the risk related with home tests. Also the possible partnership with Home Access could allow MedMira to take advantage of its patented phone support system and its counseling services. 2. Prepare a SWOT analysis for MedMira Aids Test.
Strengths
1. “Developed, manufactured and marketed rapid diagnostic tests based on a unique biotechnology platform known as flow-through assays”; 2. “MedMira rapid HIV tests platform was the only one in the world to receive regulatory
1. What changes in the environment made it possible to consider the launch of an OTC Aids Test? Be specific.
The launch of an OTC Aids Test in United States was only possible to be considered after some changes in the environment.
Due to growing incidences of infectious diseases (HIV, Hepatitis
C,…) there was a need to do something in order to overcome this issue that affected so many people. So MedMira Laboratories decided to develop rapid tests able to give accurate diagnosis that allowed healthcare providers to deliver effective treatment faster.
In the past years most of the HIV tests were performed using conventional testing technology, which required a minimum of 2 to
8 hours to produce results, highly trained laboratory personnel and special equipment to perform and interpret the tests. In order to decrease costs, these testes were normally performed in batches, which delayed the process for patients to get their results up to two weeks. So rapid HIV tests emerged as a good, faster and cheaper alternative for conventional testing technology. Rapid HIV testing was a growing market worldwide.
Advancements made in anti-retroviral treatment were also an important step to the launch of an OTC Aids Test. It changed the way people faced a positive result. Until then a positive result was often seen as a death sentence. But with these advancements made in anti-retroviral treatment it had became a much more manageable illness. This help reduced the risk related with home tests. Also the possible partnership with Home Access could allow MedMira to take advantage of its patented phone support system and its counseling services. 2. Prepare a SWOT analysis for MedMira Aids Test.
Strengths
1. “Developed, manufactured and marketed rapid diagnostic tests based on a unique biotechnology platform known as flow-through assays”; 2. “MedMira rapid HIV tests platform was the only one in the world to receive regulatory